About the Authors

Steffanie A. Strathdee

sstrathdee@health.ucsd.edu

Affiliation Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego School of Medicine, San Diego, California, United States of America

Davey M. Smith

Affiliation Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego School of Medicine, San Diego, California, United States of America

Megan Halbrook

Affiliation Fielding School of Public Health, University of California—Los Angeles, Los Angeles, California, United States of America

Placide Mbala-Kingebeni

Affiliations Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of Congo, University of Kinshasa, Kinshasa, Democratic Republic of Congo

Shira Abeles

Affiliation Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego School of Medicine, San Diego, California, United States of America

Francesca Torriani

Affiliation Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego School of Medicine, San Diego, California, United States of America

Anne Rimoin

Affiliation Fielding School of Public Health, University of California—Los Angeles, Los Angeles, California, United States of America

Competing Interests

I have read the journal’s policy and the authors of this manuscript have the following competing interests: DMS has serves as consultant for FluxErgy Inc, Brio Clinical, Bayer HealthCare, Model Medicines, Linear Therapies, Pharma Holdings, VxBiosciences, and Signant Health.